Lisheng Kong, MD
Vascular Surgery · Ventura, CANPI 1891764775
Payments from drug & device makers
Across 228 payments — averaging $60.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$4K
- Medtronic$4K
- Philips North America LLC$1K
- Imperative Care, Inc$992
- Endologix LLC$614
- Inari Medical, Inc.$600
- plus $3K from 22 others
What the payments were for
- Travel & lodging$9507%
- Food & beverage$9,03465%
- Education$761%
- Other$3,75027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 1 | $3,750 |
| Medtronic(2 entities) | 91 | $3,709 |
| Philips North America LLC | 41 | $1,419 |
| Imperative Care, Inc | 10 | $992 |
| Endologix LLC | 5 | $614 |
| Inari Medical, Inc. | 9 | $600 |
| Boston Scientific | 13 | $437 |
| Reflow Medical Inc | 3 | $427 |
| W. L. Gore & Associates, Inc. | 5 | $364 |
| Johnson & Johnson | 14 | $279 |
| Silk Road Medical, Inc. | 6 | $247 |
| Bolton Medical Inc | 1 | $130 |
| Kerecis Limited | 1 | $127 |
| Penumbra, Inc. | 1 | $118 |
| Pfizer | 8 | $115 |
| Janssen Scientific Affairs, LLC | 1 | $92 |
| Smith+Nephew | 2 | $76 |
| Vertex | 3 | $72 |
| Cardiovascular Systems Inc. | 2 | $48 |
| Lemaitre Vascular, Inc. | 3 | $33 |
| Abbott | 1 | $25 |
| Fresenius USA Marketing, Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Cagent Vascular Inc | 1 | $21 |
| Inspiremd Ltd | 1 | $21 |
| Getinge USA Sales, LLC | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$3,750
- Ellipsys$903
- PRODIGY CATHETER$859
- CONCERTOTM$551
- FLOWTRIEVER CATHETER, S$442
- CT THROMBECTOMY SYSTEM KIT$442
- Ovation$359
- GORE VIABAHN VBX Balloon Expandable Endo$182
- Endurant$170
- Abre$164
- VenaSeal$158
- ENROUTE Transcarotid Neuroprotection System$156
- ENROUTE Transcarotid Stent$156
- PHOENIX$149
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$130
- Kerecis Omega3 Wound$127
- Kerecis Omega3 Surgibind$127
- Kerecis Omega3 GraftGuide$127
- Kerecis Omega3 SurgiClose$127
- (4067) Tack Endovascular Systems BTK$125
How this compares
$13,811 in reported general payments places this provider in the 70th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 52 | $69,385 |
| XareltoRivaroxaban | 47 | $59,563 |
| ClopidogrelClopidogrel Bisulfate | 179 | $2,316 |
| Cilostazol | 75 | $1,182 |
| Atorvastatin Calcium | 71 | $554 |
| Cephalexin | 46 | $549 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $188 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $142 |
| Famotidine | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $115 | $69,38552 claims |
| Johnson & JohnsonXarelto | $279 | $59,56347 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 519 vascular surgery providers in California.
Other vascular surgery in Ventura
- Christopher SkillernVentura$80K
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
- Bernardo Curi MendesLos Angeles$376K
- Trevor DerderianRancho Mirage$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.